Matches in SemOpenAlex for { <https://semopenalex.org/work/W2252355792> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2252355792 endingPage "e22124" @default.
- W2252355792 startingPage "e22124" @default.
- W2252355792 abstract "e22124 Background: Therapeutic anti-cancer vaccine strategies have been effective in a broad range of preclinical tumor models, but clinical trials of vaccines in metastatic cancer patients have failed to show clinical benefit. We have previously shown that patients with stage IV melanoma have systemic immunosuppression including elevated plasma levels of immunosuppressive cytokines and impaired DTH responses to recall antigens. Patients with stage IV melanoma also have elevated circulating levels of the vascular growth factors vascular endothelial growth factor A (VEGF A) and placental growth factor (PlGF). Based on these observations, we have hypothesized that vascular growth factors such as VEGF and PlGF mediate systemic immunosuppression. Methods: FVB mice with established ANV6 transplantable breast tumors were bled, and plasma samples were assayed for VEGF, PlGF, and interleukin (IL)-10. Splenocytes taken from tumor-bearing mice were stimulated via the T cell receptor (TCR), and interferon gamma (IFN) production was measured. Splenocytes from normal mice were stimulated in the presence or absence of VEGF; IFN production was measured. Results: Compared with age- and sex-matched controls, tumor-bearing mice had elevated plasma levels of VEGF, PlGF, and the immunosuppressive cytokine IL-10 (see table ). Furthermore, splenocytes from tumor-bearing mice produced less IFN upon TCR stimulation than did splenocytes from control mice. Finally, normal mouse splenocytes produced less IFN when stimulated in the presence of VEGF than in its absence (70.2 ± 37.2 vs. 260.0 ± 130.9 pg/ml). Conclusions: We have shown that mice with advanced tumors exhibit both elevated levels of vascular growth factors and systemic immune inhibition. We have also shown that VEGF leads to impairment of immune function in normal splenocytes. Taken together, these results suggest that excess vascular growth factors may mediate immunosuppression in animals with advanced tumors, which may in turn impair anti-tumor vaccine efficacy. [Table: see text] No significant financial relationships to disclose." @default.
- W2252355792 created "2016-06-24" @default.
- W2252355792 creator A5000164383 @default.
- W2252355792 creator A5082719040 @default.
- W2252355792 date "2009-05-20" @default.
- W2252355792 modified "2023-10-17" @default.
- W2252355792 title "Relationship of systemic immune dysregulation in advanced tumors to vascular growth factor overproduction" @default.
- W2252355792 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.e22124" @default.
- W2252355792 hasPublicationYear "2009" @default.
- W2252355792 type Work @default.
- W2252355792 sameAs 2252355792 @default.
- W2252355792 citedByCount "0" @default.
- W2252355792 crossrefType "journal-article" @default.
- W2252355792 hasAuthorship W2252355792A5000164383 @default.
- W2252355792 hasAuthorship W2252355792A5082719040 @default.
- W2252355792 hasConcept C126322002 @default.
- W2252355792 hasConcept C134018914 @default.
- W2252355792 hasConcept C167734588 @default.
- W2252355792 hasConcept C189976730 @default.
- W2252355792 hasConcept C203014093 @default.
- W2252355792 hasConcept C2777025900 @default.
- W2252355792 hasConcept C2777658100 @default.
- W2252355792 hasConcept C2778690821 @default.
- W2252355792 hasConcept C2780252810 @default.
- W2252355792 hasConcept C49382859 @default.
- W2252355792 hasConcept C502942594 @default.
- W2252355792 hasConcept C71924100 @default.
- W2252355792 hasConcept C8891405 @default.
- W2252355792 hasConceptScore W2252355792C126322002 @default.
- W2252355792 hasConceptScore W2252355792C134018914 @default.
- W2252355792 hasConceptScore W2252355792C167734588 @default.
- W2252355792 hasConceptScore W2252355792C189976730 @default.
- W2252355792 hasConceptScore W2252355792C203014093 @default.
- W2252355792 hasConceptScore W2252355792C2777025900 @default.
- W2252355792 hasConceptScore W2252355792C2777658100 @default.
- W2252355792 hasConceptScore W2252355792C2778690821 @default.
- W2252355792 hasConceptScore W2252355792C2780252810 @default.
- W2252355792 hasConceptScore W2252355792C49382859 @default.
- W2252355792 hasConceptScore W2252355792C502942594 @default.
- W2252355792 hasConceptScore W2252355792C71924100 @default.
- W2252355792 hasConceptScore W2252355792C8891405 @default.
- W2252355792 hasIssue "15_suppl" @default.
- W2252355792 hasLocation W22523557921 @default.
- W2252355792 hasOpenAccess W2252355792 @default.
- W2252355792 hasPrimaryLocation W22523557921 @default.
- W2252355792 hasRelatedWork W1996874733 @default.
- W2252355792 hasRelatedWork W2002710000 @default.
- W2252355792 hasRelatedWork W2034985166 @default.
- W2252355792 hasRelatedWork W2069560477 @default.
- W2252355792 hasRelatedWork W2136175148 @default.
- W2252355792 hasRelatedWork W2360001602 @default.
- W2252355792 hasRelatedWork W2396486584 @default.
- W2252355792 hasRelatedWork W2402149178 @default.
- W2252355792 hasRelatedWork W2747054008 @default.
- W2252355792 hasRelatedWork W3200647722 @default.
- W2252355792 hasVolume "27" @default.
- W2252355792 isParatext "false" @default.
- W2252355792 isRetracted "false" @default.
- W2252355792 magId "2252355792" @default.
- W2252355792 workType "article" @default.